Medicis Pharmaceutical - PDFSEARCH.IO - Document Search Engine

Medicis Pharmaceutical
Results: 12

#	Item
1	1.5% Contingent Convertible Senior Notes due[removed]the “2033 Notes) Issued by Medicis Pharmaceutical Corporation (“Medicis”) On December 11, 2012, Valeant Pharmaceuticals International, Inc. completed its acquisiti Add to Reading List Source URL: www.valeant.com Language: English - Date: 2012-12-11 11:10:26 Tort law Mergers and acquisitions Medicis Pharmaceutical Government procurement in the United States Business Law Conversion Personal property law
2	1.375% Convertible Senior Notes due[removed]the “2017 Notes”) Issued by Medicis Pharmaceutical Corporation (“Medicis”) On December 11, 2012, Valeant Pharmaceuticals International, Inc. completed its acquisition of Add to Reading List Source URL: www.valeant.com Language: English - Date: 2012-12-11 11:02:54 Adjustment Conversion Religious conversion
3	2.5% Contingent Convertible Senior Notes due[removed]the “2032 Notes) Issued by Medicis Pharmaceutical Corporation (“Medicis”) On December 11, 2012, Valeant Pharmaceuticals International, Inc. completed its acquisiti Add to Reading List Source URL: www.valeant.com Language: English - Date: 2012-12-11 11:12:49 Mergers and acquisitions Business Companies listed on the New York Stock Exchange Medicis Pharmaceutical Conversion
4	Final Ammonul DHP Letter Future Lots Add to Reading List Source URL: www.fda.gov Language: English MedWatch Medicis Pharmaceutical Syringe filter Medicinal chemistry Food and Drug Administration Pharmaceutical sciences Clinical research
5	Appendix[removed]: Protocol and Protocol Amendments (MA[removed]) Add to Reading List Source URL: www.fda.gov Language: English Design of experiments Pharmacology Drug safety Institutional review board Clinical trial Lip enhancement Restylane Investigational New Drug Medicis Pharmaceutical Medicine Clinical research Pharmaceutical industry
6	Cover Letter[removed]): P040024/S051 - April 27, 2011 Advisory Panel Pack Materials Add to Reading List Source URL: www.fda.gov Language: English Oral surgery Plastic surgery Glycosaminoglycans Otolaryngology Restylane Medicis Pharmaceutical Lip enhancement Food and Drug Administration Medicine Surgery Oral and maxillofacial surgery
7	FDA and Medicis Meeting Minutes February 23, 2011-Panel Pack Contents Discussion Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Oral and maxillofacial surgery Oral surgery Glycosaminoglycans Otolaryngology Restylane Medicis Pharmaceutical Food and Drug Administration Clinical trial Medicine Health Pharmaceutical sciences
8	P040024 Panel Track Supplement: Page 19, Indications for Use Statement Add to Reading List Source URL: www.fda.gov Language: English Oral and maxillofacial surgery Otolaryngology Glycosaminoglycans Oral surgery Restylane Hyaluronan Lip enhancement Rhytidectomy Medicis Pharmaceutical Medicine Surgery Plastic surgery
9	New Claim: Increased Duration of Restylane® Following Re-injection Add to Reading List Source URL: www.fda.gov Language: English Oral and maxillofacial surgery Oral surgery Glycosaminoglycans Otolaryngology Restylane Lip enhancement Hyaluronan Medicis Pharmaceutical Nasolabial fold Medicine Surgery Plastic surgery
10	P040024 Panel Track Supplement: Page 19, Indications for Use Statement Add to Reading List Source URL: www.fda.gov Language: English Oral and maxillofacial surgery Otolaryngology Glycosaminoglycans Oral surgery Restylane Hyaluronan Lip enhancement Rhytidectomy Medicis Pharmaceutical Medicine Surgery Plastic surgery

UPDATE